diseas
fmd
becom
major
problem
affect
mani
livestock
agricultur
import
sever
countri
across
differ
contin
fmd
spread
rapidli
wide
grave
econom
consequ
becom
one
anim
diseas
livestock
owner
fear
outbreak
fmd
cattl
swine
unit
kingdom
recent
focus
worldwid
attent
deadli
anim
diseas
member
famili
picornaviru
diseas
viru
fmdv
icosahedr
viru
protein
capsid
enclos
singl
strand
posit
sens
rna
infect
viral
genom
translat
cleav
via
viral
proteas
matur
structur
protein
capsid
consist
four
protein
assembl
surfac
viral
particl
fold
wherea
intern
core
protein
less
structur
conserv
immunolog
studi
fmdv
identifi
linear
conform
site
present
empti
capsid
virion
antisera
rais
empti
capsid
serolog
specif
indistinguish
sera
prepar
fmd
virion
capsid
protein
shown
contain
major
antigen
determin
instanc
protein
peptid
vaccin
although
total
reactiv
antibodi
high
level
neutral
antibodi
comparison
low
propos
loop
natur
occur
viru
could
display
multipl
conform
may
elicit
differ
popul
antibodi
immun
respons
due
appar
complex
variou
immun
reactiv
gener
viru
fmdv
may
serv
attract
experiment
model
studi
vaccin
direct
immunogen
encod
cdna
vector
undergo
endogen
process
pathway
transgen
express
host
cell
may
lead
effect
humor
protect
immun
immun
respons
fmdv
shown
therefor
dna
vaccin
strategi
may
also
serv
good
strategi
solicit
humor
immun
respons
anim
immun
inactiv
vaccin
good
correl
neutral
antibodi
protect
observ
correl
well
establish
anim
immun
vaccin
strategi
limit
probabl
reflect
difficulti
reproduc
mimick
immunogen
entir
viral
particl
use
simpl
antigen
prepar
variou
piec
evid
suggest
simpler
epitop
composit
vaccin
lower
chanc
confer
solid
protect
natur
isol
virus
therefor
new
vaccin
strategi
may
need
employ
mani
epitop
permut
repres
viru
particl
previous
mason
colleagu
develop
two
type
dna
vaccin
fmdv
serotyp
one
contain
cdna
fmdv
genom
cdna
construct
contain
proteas
encod
region
shown
elicit
neutral
antibodi
partial
protect
test
pig
viral
infect
accord
cdna
construct
seem
capsid
format
situ
requir
effect
immun
immunogen
produc
capsid
assembl
may
provid
efficaci
conform
epitop
huang
et
al
wong
et
al
design
anoth
approach
sever
plasmid
encod
variou
fmdv
epitop
lead
signal
peptid
sequenc
employ
studi
swine
inocul
pcei
plasmid
encod
two
major
epitop
site
c
fmdv
serotyp
host
self
immunoglobulin
provid
protect
direct
fmdv
challeng
discrimin
differ
vaccin
anim
reduc
potenti
risk
dna
vaccin
intent
includ
viral
gene
eg
express
vector
design
evalu
three
differ
strategi
cdna
construct
transgen
express
whole
capsid
protein
two
physic
mean
direct
dna
deliveri
vivo
employ
studi
includ
transfect
skin
muscl
tissu
respect
possibl
applic
current
experiment
system
futur
vaccin
virolog
studi
fmdv
discuss
prepar
fmd
serotyp
taiwan
virus
epidem
strain
gener
gift
nation
institut
anim
health
niah
tansui
taipei
taiwan
fmdv
propag
babi
hamster
kidney
bhk
cell
host
cell
first
cultur
complet
rpmi
medium
gibco
monolay
approxim
confluenc
form
fmdv
ad
infect
cell
min
condit
cultur
medium
collect
cytopathogen
effect
cell
reach
fresh
prepar
use
within
day
store
frozen
use
studi
use
vector
modifi
mammalian
express
vector
contain
marker
kanamycin
resist
select
e
coli
intron
sequenc
immedi
follow
cmv
promot
express
mammalian
cell
construct
dna
immun
brief
plasmid
contain
capsid
protein
cdna
leader
sequenc
pseudorabi
viru
glycoprotein
c
link
cdna
capsid
precursor
protein
cdna
gene
fmdv
type
respect
gene
fragment
purifi
agaros
gel
subclon
ecor
site
bamh
site
vector
follow
standard
clone
procedur
plasmid
subclon
plasmid
contain
leader
sequenc
pseudorabi
viru
glycoprotein
c
gener
gift
dr
chang
digest
hind
iii
ecor
ligat
vector
prepar
vector
contain
viral
structur
protein
result
ligat
mixtur
use
transform
e
coli
compet
cell
gibco
grand
island
ny
usa
restrict
endonucleas
digest
map
authent
sequenc
insert
dna
verifi
abi
autosequ
analysi
construct
plasmid
subsequ
purifi
use
endofre
plasmid
mega
kit
qiagen
ca
usa
found
contain
less
euml
endotoxin
determin
use
limulu
amoebocyt
lysat
analysi
kit
biowhittak
capsid
protein
express
e
coli
purifi
refold
describ
previous
wang
et
al
concentr
purifi
viral
protein
determin
measur
optic
densiti
nm
protein
subject
western
blot
analysi
antibodi
verif
authent
purifi
viral
protein
use
elisa
test
antigen
sourc
helium
gene
gun
use
vivo
vitro
dna
transfect
previous
describ
plasmid
dna
precipit
onto
gold
particl
use
coat
method
dnagold
particl
prepar
coat
onto
inner
surfac
tefzel
tube
presenc
mgml
polyvinylpyrrolidon
sigma
cut
inch
segment
use
dna
cartridg
dna
cartridg
studi
made
deliv
mg
gold
particl
plasmid
dna
gene
transfer
experi
perform
cell
cultur
mous
pig
skin
tissu
test
anim
aliquot
cell
per
mm
dish
blast
vitro
use
helio
gene
gun
laboratori
ca
usa
burst
pressur
psi
dna
deliveri
vivo
abdomin
skin
tissu
test
mice
pig
carri
discharg
pressur
psi
respect
transfect
cell
mous
pig
skin
tissu
harvest
h
express
transgen
protein
detect
stain
western
bolt
analysi
rabbit
polyclon
antibodi
dna
transfect
skin
test
mice
pig
carri
use
helio
gene
gun
system
cartridg
contain
plasmid
dna
eg
vector
prepar
describ
three
test
group
balbcbyj
mice
anim
care
center
taipei
taiwan
immun
express
vector
five
mice
per
group
immun
test
dna
three
five
time
interv
week
direct
gene
deliveri
vivo
electropor
perform
previous
describ
kadowaki
et
al
plasmid
dna
salin
pb
inject
tibiali
anterior
ta
muscl
balbcbyj
immedi
electropor
puls
electr
use
array
electrod
btx
san
diego
ca
usa
mm
distanc
electrod
insert
longitudin
rel
muscl
fiber
six
puls
v
given
btx
squar
wave
gener
rate
one
puls
per
second
last
ms
group
mice
n
electropor
plasmid
dna
interv
total
four
time
serum
sampl
test
mice
collect
day
day
vaccin
mice
challeng
week
third
boost
blood
sampl
test
mice
collect
elisa
test
viru
challeng
experi
perform
day
post
booster
inject
one
group
mice
immun
inject
ml
commerci
avail
convent
fmdv
vaccin
aftopor
serotyp
taiwan
merial
anim
health
ltd
biolog
laboratori
uk
serv
posit
control
studi
yet
anoth
group
mice
receiv
treatment
serv
neg
control
viru
challeng
experi
adult
balbcbyj
mice
without
prior
vaccin
treatment
inject
intraperiton
viru
suspens
ml
contain
viru
particl
k
strain
fmdv
blood
withdrawn
test
mice
day
individu
blood
sampl
ad
cell
cultur
incub
gentl
rock
min
cell
sheet
wash
twice
medium
incub
fresh
medium
supplement
fetal
calf
serum
fc
day
presenc
presenc
viru
titer
sera
test
mice
quantit
determin
appear
cytopath
effect
cpe
fmdv
cell
cultur
viru
clearanc
determin
absenc
viru
sera
test
mice
day
elisa
use
determin
titer
antibodi
brief
purifi
recombin
protein
pb
adsorb
directli
onto
immunopl
concentr
overnight
plate
wash
three
time
pbst
pb
contain
block
skim
milk
pb
h
sera
test
fix
dilut
seri
incub
h
plate
wash
treat
suitabl
concentr
biotinyl
igg
antibodi
h
subsequ
plate
wash
dilut
vector
ca
usa
ad
plate
incub
h
plate
wash
enzym
substrat
sigma
ad
reaction
carri
room
temperatur
min
final
equal
volum
n
ad
stop
reaction
absorb
nm
measur
elisa
reader
method
describ
previous
wang
et
al
employ
brief
sera
test
anim
inactiv
min
test
control
serum
sampl
ad
well
end
row
tissu
cultur
plate
dilut
serial
dilut
across
plate
fifti
microlit
viru
suspens
ad
well
plate
vortex
min
incub
min
cell
suspens
cellsml
eagl
mem
contain
fc
ad
well
plate
incub
addit
h
number
surviv
cell
determin
titer
express
reciproc
final
serum
dilut
result
neutral
viral
activ
adher
cell
layer
grown
cultur
plate
wash
pb
incub
polyclon
rabbit
antibodi
min
room
temperatur
sampl
wash
stain
goat
isothiocyan
fitc
sampl
analyz
microscopi
transgen
express
fmdv
structur
protein
precursor
detect
immunolog
standard
western
blot
analysi
brief
transfect
skin
tissu
collect
test
anim
excis
small
uniform
portion
target
skin
area
skin
sampl
cut
scissor
minc
sonic
within
extract
buffer
triton
proteas
inhibitor
cocktail
roch
pb
crude
tissu
extract
spun
g
min
mix
equal
volum
sampl
buffer
boil
min
sampl
subject
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
transfer
pvdf
polyvinyliden
difluorid
membran
blot
block
use
skim
milk
pb
incub
polyclon
rabbit
antibodi
pb
h
wash
three
time
pbst
treat
goat
biotinyl
igg
antibodi
dilut
vector
ca
usa
h
subsequ
membran
wash
dilut
ad
test
blot
incub
h
membran
wash
stain
enhanc
chemiluminesc
amersham
pharmacia
biotech
adher
cell
layer
grown
cultur
plate
wash
pb
fix
formaldehyd
pb
min
wash
pb
block
normal
hors
serum
cell
sampl
incub
polyclon
rabbit
antibodi
saponin
pb
h
room
temperatur
test
sampl
wash
stain
goat
isothiocyan
fitc
secondari
antibodi
cell
sampl
examin
photograph
microscopi
use
epilumin
olympu
fluoresc
scope
origin
fmdv
serotyp
taiwan
prepar
offici
legal
provid
nation
institut
anim
health
dr
jong
niah
taiwan
use
viral
rna
extract
cdna
fragment
construct
use
laboratori
facil
niah
clone
isol
two
fmdv
cdna
gene
fragment
includ
kb
cdna
encod
protein
kb
cdna
encod
ie
contain
viral
protein
sequenc
whole
capsid
structur
protein
precursor
cdna
fragment
proteas
gene
subsequ
termin
sequenc
total
delet
due
consider
elimin
potenti
risk
viral
dna
vaccin
design
potenti
futur
applic
livestock
anim
dna
vaccin
adapt
function
verifi
sequenc
cmv
promoterenhanc
sequenc
clinic
mammalian
gene
express
vector
system
ie
plasmid
vector
pwrg
guid
use
food
drug
administr
usa
recommend
use
human
gene
therapi
clinic
trial
subclon
two
test
fmdv
viral
protein
cdna
clone
express
plasmid
use
luciferas
transgen
report
assay
demonstr
promot
confer
approxim
transient
luciferas
activ
standard
commerci
avail
cmv
promot
pnass
clontech
palo
alto
ca
usa
promot
vector
henc
employ
rest
studi
order
establish
helio
gene
gun
system
effect
appli
current
dna
vaccin
experi
perform
number
refer
test
verifi
effici
mous
skin
gene
transfect
system
lux
cdna
vector
blast
onto
mous
skin
ng
transgen
lux
protein
per
skin
tissu
site
obtain
h
comparison
ng
transgen
lux
protein
per
cell
per
h
detect
vitro
transfect
condit
dose
ng
haat
cdna
express
vector
shown
produc
ng
transgen
haat
protein
induc
readili
detect
level
antibodi
haat
protein
gene
gunskin
immun
balbc
mice
result
henc
establish
efficaci
dna
vaccin
use
helio
gene
gun
also
import
note
level
report
transgen
express
obtain
helio
gun
close
level
previous
establish
gene
gun
devic
evalu
efficaci
gene
gun
versu
electropor
transfect
transgen
express
dna
immun
eg
product
antibodi
use
report
system
human
haat
cdna
vaccin
respect
abdomin
skin
tissu
balbcbyj
mice
n
transfect
plasmid
dna
gene
gun
altern
muscl
tissu
two
hind
leg
balbcbyj
mice
transfect
luciferas
plasmid
dna
via
intramuscular
inject
follow
electropor
h
test
tissu
sampl
extract
luminomet
assay
perform
luciferas
activ
dna
immun
cdna
similarli
transfect
mice
use
two
method
mean
serum
titer
antibodi
test
mice
n
assay
elisa
two
experi
n
micetest
group
observ
higher
transgen
activ
obtain
electropor
method
ie
rlusit
compar
gene
gun
method
ie
rlusit
higher
antibodi
titer
obtain
electropor
method
ie
reciproc
titer
compar
gene
gun
method
ie
reciproc
titer
result
impli
transient
express
level
test
report
dna
vaccin
transgen
obtain
differ
dna
deliveri
method
may
effect
vaccin
reflect
proport
efficaci
product
antibodi
verifi
pig
serum
provid
niah
use
antibodi
sourc
studi
gener
recombin
protein
e
coli
purifi
refold
use
antigen
protein
produc
antibodi
standard
elisa
western
blot
analysi
use
verif
quantif
transgen
viral
protein
shown
figur
transgen
express
protein
effect
detect
cell
figur
mous
skin
tissu
figur
use
cdna
express
vector
one
day
transfect
vivo
express
transgen
fmdv
polypeptid
pig
skin
tissu
appar
molecular
weight
respect
predict
experiment
result
obtain
western
blot
analysi
antibodi
figur
sinc
antiserum
avail
studi
unabl
evalu
express
protein
experi
previous
research
report
use
pig
guinea
pig
suckl
mice
anim
model
vaccin
viral
challeng
experi
fmdv
fmdv
replic
cytoplasm
host
cell
new
viru
particl
gener
larg
number
within
cytosol
time
infect
cell
destroy
new
viru
particl
releas
infect
cell
studi
adult
mous
month
old
system
found
infect
fmdv
first
appear
test
mous
blood
minut
replic
blood
h
viru
particl
via
intraperiton
ip
inject
howev
viru
titer
decreas
eventu
clear
serum
test
mice
addit
day
found
balbc
mice
first
immun
commerci
avail
kill
viru
vaccin
current
dna
vaccin
strategi
inocul
highli
infecti
fmd
viru
viremia
clear
viru
day
instead
day
control
mice
figur
symptom
detect
mice
adult
mous
challeng
model
base
cytopath
effect
cpe
assay
clearanc
viru
particl
serum
collect
day
inject
challeng
fmdv
use
protocol
observ
viru
particl
routin
total
clear
day
test
mice
vaccin
commerci
obtain
kill
viru
vaccin
contrast
naiv
empti
mice
routin
still
suffer
high
medium
level
viremia
first
day
viral
challeng
figur
result
suggest
strongli
littl
viru
replic
vaccin
mice
adult
mous
system
thu
provid
conveni
quick
assay
evalu
molecular
dna
vaccin
strategi
fmdv
see
cohort
balbc
mice
systemat
vaccin
use
helio
gene
gun
cdna
express
vector
balbc
mice
variou
experiment
condit
via
gene
gun
seri
experi
regim
one
prime
day
two
booster
day
dna
transfect
test
mice
monitor
sera
collect
analyz
transgen
antigen
protein
express
product
neutral
antibodi
test
mice
observ
dna
vaccin
plasmid
vector
express
alon
routin
induc
low
level
antibodi
detect
level
antibodi
activ
test
mice
provid
import
neg
baselin
studi
tabl
replic
experi
perform
mice
test
result
shown
tabl
similar
result
alway
obtain
contrast
howev
skin
dna
vaccin
cdna
construct
express
precursor
polypeptid
four
fmdv
capsid
protein
name
induc
antibodi
protein
well
neutral
antibodi
fmdv
result
signific
protect
immun
viru
clearanc
test
mice
tabl
vivo
gene
transfer
intramuscular
inject
dna
follow
situ
electropor
anoth
physic
mean
effect
gene
vaccin
experiment
anim
system
tabl
show
similar
result
obtain
dna
immun
method
compar
gene
gun
method
neutral
antibodi
titer
viru
clearanc
test
mice
detect
immun
cdna
plasmid
vivo
electropor
deliveri
muscl
tissu
furthermor
result
obtain
two
independ
gene
deliveri
method
obtain
without
use
fmdv
viral
gene
dna
ie
cdna
gene
fmdv
includ
transgen
express
current
vector
construct
one
cdna
immun
mous
experi
antibodi
elisa
titer
neutral
antibodi
titer
found
high
respect
mous
challeng
experi
mice
immun
cdna
express
plasmid
found
effect
quickli
clear
infect
fmdv
particl
wherea
control
anim
could
clear
viru
rapidli
tabl
sinc
dna
vaccin
design
often
make
use
limit
fragment
viral
genom
cdna
henc
littl
chanc
live
viral
infect
would
otherwis
often
happen
contamin
live
viru
escap
inactiv
process
make
vaccin
reason
design
dna
vaccin
vector
without
incorpor
gene
base
safeti
consider
exact
process
viral
capsid
protein
creat
authent
viral
capsid
process
specif
viral
proteas
envis
turn
might
gener
novel
recombin
viru
host
type
viru
eg
viru
assembl
level
specul
sever
acut
respiratori
syndrom
sar
viru
may
gener
hybrid
viru
human
wild
anim
coronavirus
current
dna
vaccin
strategi
believ
may
elimin
remot
possibl
suckl
mice
protect
assay
previous
employ
use
method
vaccin
studi
fmdv
serv
indic
neutral
antibodi
present
adult
test
mous
serum
shown
confer
good
correl
protect
assay
studi
instead
establish
similar
conveni
faster
assay
method
challeng
clearanc
fmdv
use
adult
mous
system
seen
figur
repeatedli
observ
compar
control
set
mice
vaccin
viru
clearanc
day
earlier
total
lack
fmd
viru
titer
effect
obtain
vaccin
mice
either
immun
current
dna
vaccin
commerci
avail
inactiv
viru
vaccin
assay
like
day
transient
transgen
luciferas
activ
assay
may
henc
serv
effici
larg
sampl
number
surrog
assay
system
futur
studi
viru
challeng
clearanc
protect
fmdv
system
shown
figur
relat
experi
short
viremia
period
detect
studi
use
protocol
employ
viru
titer
dosag
viru
particl
k
strain
fmdv
adult
balbcbyj
mice
host
anim
present
studi
day
shorter
period
viral
clearanc
prove
experiment
distinguish
use
assay
dna
vaccin
also
studi
peptid
vaccin
fmdv
previous
report
result
show
assay
sensit
enough
spectrum
studi
vaccin
efficaci
would
interest
investig
futur
studi
whether
variou
vaccin
vaccin
differ
vaccin
dosag
confer
substanti
differ
viral
clearanc
activ
vaccin
efficaci
pig
could
also
effect
distinguish
within
specif
time
point
day
period
current
mous
model
far
accumul
enough
data
evalu
possibl
sinc
appar
correl
viral
clearanc
activ
product
neutral
antibodi
believ
may
also
desir
correl
viral
clearanc
time
titer
neutral
antibodi
futur
experi
necessari
assess
possibl
current
adult
mous
system
show
whole
fmdv
capsid
cdna
sequenc
without
presenc
ie
viral
proteas
protein
elicit
signific
level
neutral
antibodi
confer
effect
level
protect
viral
challeng
fmdv
previou
studi
shown
whole
viru
particl
authent
empti
capsid
assembl
import
induct
neutral
antibodi
protect
viral
challeng
comparison
current
result
efficaci
dna
vaccin
lack
dna
vaccin
may
explain
follow
possibl
firstli
transgen
protein
produc
mous
epiderm
cell
serv
effect
immunogen
studi
yet
contrast
andor
protein
moieti
multipl
subunit
polyprotein
singl
chain
transgen
protein
howev
serv
potent
immunogen
presum
present
differ
protein
fold
free
singl
unit
transgen
protein
secondli
transgen
protein
consist
fmd
protein
compon
viru
capsid
may
abl
form
kind
modifi
structur
assembl
protein
aggreg
test
mous
skin
cell
effect
strong
viral
immunogen
third
possibl
endogen
proteas
eg
chymotrypsin
activ
mous
host
cell
may
process
transgen
protein
efficaci
configur
conform
result
product
viral
protein
novel
fold
serv
potent
viral
protein
epitop
western
blot
analys
figur
show
precursor
polypeptid
transient
express
low
readili
detect
level
differ
anim
use
observ
increas
abund
protein
experi
correct
size
transgen
protein
deriv
host
cell
process
clearli
detect
high
level
test
pig
skin
tissu
cdna
express
construct
result
suggest
authent
intact
transgen
viral
protein
produc
immun
anim
xing
et
al
studi
interact
multipl
domain
fmdv
involv
protein
topic
structur
fmdv
find
collabor
studi
led
us
suggest
protein
aggreg
particl
vlp
transgen
product
may
exist
transient
rel
low
frequenc
futur
studi
use
scan
electron
microscopi
protein
biochemistri
techniqu
requir
discern
actual
molecular
mechan
immunogen
capsid
protein
shown
confer
mostli
loop
comparison
previou
work
immun
respons
obtain
e
recombin
capsid
protein
observ
studi
dna
vaccin
encod
protein
much
less
immunogen
equival
dose
antigen
prepar
administ
form
recombin
protein
mice
throughout
multipl
independ
experi
use
dna
vaccin
plasmid
vector
express
cdna
detect
effect
product
neutral
antibodi
viru
clearanc
total
test
mice
seen
tabl
lack
immun
respons
cdna
vaccin
compar
cdna
vaccin
may
due
number
reason
first
lack
appropri
fold
transgen
test
mous
skin
tissu
tibiali
anterior
ta
muscl
second
antigen
present
protein
favor
test
skin
muscl
tissu
third
short
inappropri
transgen
protein
process
express
antigen
test
host
cell
fourth
immun
respons
pathway
skin
tissu
ta
muscl
may
low
result
threshold
activ
futur
studi
need
investig
possibl
summari
shown
fmdv
replic
blood
test
mice
infect
intraperiton
inject
viru
particl
express
four
fmdv
capsid
protein
sequenc
singl
polypeptid
molecul
cdna
vector
via
skin
muscl
dna
vaccin
could
elicit
signific
immun
respons
ie
neutral
antibodi
fmdv
provid
protect
viral
challeng
adult
balbc
mous
system
current
experiment
system
creat
potenti
futur
studi
complet
set
viral
capsid
protein
precursor
molecul
dna
vaccin
relat
molecular
strategi
develop
futur
fmdv
viru
dna
vaccin
research
molecular
mechan
target
viru
eg
host
cell
process
assembl
protein
compon
without
viral
proteas
could
investig
use
current
gene
deliverymous
evalu
system
